Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs Willow

Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Published by The GLP-1 Verdict

Pricing sources checked: CoreAge Rx: August 2026 · Willow: October 2026

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade C · #154

Willow

Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats.

Visit Willow

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 68/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Willow still earns its place — shoppers who want mainstream telehealth GLP-1 access.

The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results75
97Price honesty64
96Prescriber access57
88Formulary choice88
95Cancellation fairness56
93Member support70

Price, coverage & features

MetricCoreAge RxWillow
Verdict Score94/10068/100
GradeAC
Semaglutide$99/moFrom $299/mo (compounded, injection or tablets)
Tirzepatide$149/moFrom $399/mo (compounded, injection or tablets)
CoverageAll 50 states36 states (Willow's FAQ list; not AL, AK, AR, DE, KS, LA, MS, ND, RI, SD, UT, WV)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoYes

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Willow

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Serves 36 states, and does not accept anyone with diabetes

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

Shoppers who want mainstream telehealth GLP-1 access.

Visit Willow Read the full Willow review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Willow does the reverse.

Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.